Breaking News, Promotions & Moves

Harbour BioMed Appoints Adam Zong, PhD, President

Zong comes from Arc Nouvel Clinical Development Consulting, where he was principal consultant.

Author Image

By: Patrick Lavery

Content Marketing Editor

Harbour BioMed, a biopharmaceutical company discovering and developing novel antibody therapeutics, is welcoming Adam Zong, PhD, as its new President. Zong will be based in Shanghai and report directly to Harbour BioMed Founder, Chairman, and CEO Jingsong Wang, MD, PhD. Previous Experience of New President Prior to this new appointment, Zong was Principal Consultant at Arc Nouvel Clinical Development Consulting. Also, he was the founding Chief Executive Officer of Hengrui Therapeutics U...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters